Capital International Inc. CA Has $17.43 Million Holdings in Corteva, Inc. $CTVA

Capital International Inc. CA lowered its stake in Corteva, Inc. (NYSE:CTVA) by 59.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 259,963 shares of the company’s stock after selling 388,736 shares during the period. Capital International Inc. CA’s holdings in Corteva were worth $17,425,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in CTVA. Brighton Jones LLC lifted its position in shares of Corteva by 307.2% in the fourth quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock worth $888,000 after buying an additional 11,760 shares during the last quarter. Woodline Partners LP lifted its position in shares of Corteva by 40.3% during the 1st quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock worth $3,645,000 after purchasing an additional 16,644 shares during the last quarter. EverSource Wealth Advisors LLC lifted its position in shares of Corteva by 62.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company’s stock worth $191,000 after purchasing an additional 980 shares during the last quarter. Cresset Asset Management LLC lifted its position in shares of Corteva by 2.6% during the 2nd quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock worth $526,000 after purchasing an additional 181 shares during the last quarter. Finally, Jump Financial LLC acquired a new position in shares of Corteva during the 2nd quarter worth about $1,464,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Trading Up 0.0%

Shares of CTVA opened at $77.06 on Monday. Corteva, Inc. has a 12-month low of $60.53 and a 12-month high of $85.63. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. The firm has a market capitalization of $51.54 billion, a price-to-earnings ratio of 45.33, a P/E/G ratio of 2.36 and a beta of 0.57. The stock’s 50-day moving average price is $81.17 and its 200 day moving average price is $75.01.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The firm had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. During the same period in the previous year, the company posted $1.13 earnings per share. The company’s quarterly revenue was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, research analysts predict that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be paid a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date is Monday, June 1st. Corteva’s payout ratio is currently 42.35%.

Analysts Set New Price Targets

Several research firms recently weighed in on CTVA. Argus boosted their price objective on Corteva from $80.00 to $91.00 and gave the stock a “buy” rating in a research report on Tuesday, March 31st. Jefferies Financial Group boosted their price objective on Corteva from $95.00 to $97.00 in a research report on Thursday, May 7th. Wells Fargo & Company boosted their price objective on Corteva from $85.00 to $90.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 21st. Citigroup boosted their price objective on Corteva from $83.00 to $85.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. Finally, Weiss Ratings raised Corteva from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, May 7th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $88.67.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.